---
title: Cardiovascular Epidemiology in Russian Federation
nct_id: NCT02449460
overall_status: UNKNOWN
sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
study_type: OBSERVATIONAL
primary_condition: Hypertension
countries: Russia
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02449460.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02449460"
ct_last_update_post_date: 2016-08-02
last_seen_at: "2026-05-12T06:55:21.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Cardiovascular Epidemiology in Russian Federation

**Official Title:** Multicenter Observational Study of Epidemiology of Cardiovascular Diseases and Risk Factors in Different Regions of Russian Federation

**NCT ID:** [NCT02449460](https://clinicaltrials.gov/study/NCT02449460)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 18000
- **Lead Sponsor:** Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- **Collaborators:** National Research Center for Preventive Medicine, Russian Cardiology Research and Production Center
- **Conditions:** Hypertension, Coronary Artery Disease, Diabetes, Heart Failure, Smoking, Lifestyle
- **Start Date:** 2012-07
- **Completion Date:** 2022-12
- **CT.gov Last Update:** 2016-08-02

## Brief Summary

The study addresses epidemiology of cardiovascular risk factors and major cardiovascular diseases in Russian Federation (urban and rural population). 12 regions of 1600 participants in each will be included.

## Detailed Description

Plasma lipids and fasting glucose, heart rate and blood pressure, anthropometry, smoking and alcohol questionaries, nutrition, sleep quality, stress will be assessed. ECG records are obtained form all participants. Subclinical target organ damage (carotid and periferal atherosclerosis, pulse wave velocity) will be measured in selected sites. Brain natriuretic peptide, adipose tissue cytokines, hsCRP and genetic markers are also under evaluation

## Eligibility

- **Minimum age:** 25 Years
- **Maximum age:** 65 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

\- informed consent

Exclusion Criteria:

No
```

## Primary Outcomes

- **all cause mortality** _(time frame: 10 years)_ — all cause motality registered by official statistics

## Secondary Outcomes

- **Stroke** _(time frame: 10 years)_
- **Miocardial infarction** _(time frame: 10 years)_
- **Cardiovascular mortality** _(time frame: 10 years)_

## Locations (2)

- Orenburg Medical Academi, Orenburg, Russia — _RECRUITING_
- Samara Medical University, Samara, Russia — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.orenburg medical academi|orenburg||russia` — added _(2026-05-12)_
- `locations.samara medical university|samara||russia` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02449460.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02449460*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*